On Invalid Date, Quoin Pharmaceuticals (NASDAQ: QNRX) reported Q4 2023 earnings per share (EPS) of N/A, up N/A year over year. Total Quoin Pharmaceuticals earnings for the quarter were -$2.05 million. In the same quarter last year, Quoin Pharmaceuticals's earnings per share (EPS) was N/A.
As of Q2 2024, Quoin Pharmaceuticals's earnings has grown year over year. Quoin Pharmaceuticals's earnings in the past year totalled -$8.69 million.
What is QNRX's earnings date?
Quoin Pharmaceuticals's earnings date is Invalid Date. Add QNRX to your watchlist to be reminded of QNRX's next earnings announcement.
What was QNRX's revenue last quarter?
On Invalid Date, Quoin Pharmaceuticals (NASDAQ: QNRX) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Quoin Pharmaceuticals's revenue was $0.00.
What was QNRX's revenue growth in the past year?
As of Q2 2024, Quoin Pharmaceuticals's revenue has grown null year over year. Quoin Pharmaceuticals's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.